shRNAs of CK1ε or MELK significantly inhibited the viability of primary VTC-001 and VTC-002 cells (Fig. 2C), consistent with the results from GBM cell lines (Fig. 2A,B). The gene discussed is MELK; the disease is glioblastoma.